Department of Ophthalmology, Ege University, Izmir, Türkiye.
Department of Microbiology, Ege University, Izmir, Türkiye; and.
Cornea. 2023 Sep 1;42(9):1179-1182. doi: 10.1097/ICO.0000000000003270. Epub 2023 Mar 3.
PURPOSE: The aim of this study was to report a case of fungal keratitis with subsequent corneal perforation after corneal collagen cross-linking (CXL) treatment performed for keratoconus. CASE REPORT: A 20-year-old woman presented with redness and discharge in the left eye. She had a history of bilateral CXL procedure performed for keratoconus elsewhere 4 days earlier. The visual acuity was hand motion in the left eye. Slit-lamp examination revealed extended corneal melting with surrounding infiltrates. The patient was hospitalized, and corneal epithelial scraping samples were sent for microbiological assessment. In the meantime, empirical antibiotic therapy (fortified topical antibiotics: vancomycin 50 mg/mL, ceftazidime 50 mg/mL, and fluconazole 2 mg/mL q1 hour) was initiated. In direct microscopy of the corneal scraping, septate hyaline fungal hyphae were detected and topical fluconazole was switched to topical voriconazole (10 mg/mL). Three days after hospitalization, corneal melting progressed to perforation and corneal suturing with 10-0 monofilament was performed to reform the anterior chamber. Complete resolution of keratitis with residual scarring was noticed in 2 weeks. Three months later, penetrating keratoplasty was performed to obtain better visual acuity. CONCLUSIONS: CXL with riboflavin has become a common procedure to prevent keratoconus progression by strengthening the biomechanical specialties of the cornea. Although the treatment itself has been used in the management of microbial keratitis and related corneal melting, fungal keratitis and corneal perforation after a CXL procedure for keratoconus might also be detected. Clinicians should be aware of this rare but devastating complication of CXL treatment and start prompt treatment when suspected.
目的:本研究旨在报告一例真菌性角膜炎病例,该患者在接受用于治疗圆锥角膜的角膜胶原交联(CXL)治疗后发生角膜穿孔。
病例报告:一名 20 岁女性因左眼发红和分泌物就诊。她在 4 天前因双侧圆锥角膜在其他地方接受了 CXL 治疗。左眼视力为手动。裂隙灯检查显示角膜广泛融解伴周围浸润。患者住院,并送检角膜上皮刮片进行微生物评估。在此期间,给予经验性抗生素治疗(强化局部抗生素:万古霉素 50mg/mL、头孢他啶 50mg/mL 和氟康唑 2mg/mL,每 1 小时 1 次)。直接显微镜检查角膜刮片时,发现有分隔的透明真菌菌丝,并将局部氟康唑换为局部伏立康唑(10mg/mL)。住院 3 天后,角膜融解进展为穿孔,并进行了 10-0 单丝角膜缝合术以重建前房。2 周后,角膜炎完全缓解,遗留瘢痕。3 个月后,行穿透性角膜移植术以获得更好的视力。
结论:使用核黄素的 CXL 已成为一种常见的方法,通过增强角膜的生物力学特性来预防圆锥角膜的进展。尽管该治疗本身已用于微生物性角膜炎和相关的角膜融解的治疗,但也可能会发现用于治疗圆锥角膜的 CXL 术后真菌性角膜炎和角膜穿孔。临床医生应意识到 CXL 治疗的这种罕见但严重的并发症,并在怀疑时及时开始治疗。
Cochrane Database Syst Rev. 2015-3-24
Graefes Arch Clin Exp Ophthalmol. 2025-3
Cochrane Database Syst Rev. 2015-4-9
Int Ophthalmol. 2024-11-11